The effectiveness of whey proteins in prevention and treatment of cancer: a review.
Anjana ThampyMeena Kumari Palani KumarMuthuKumar Serva PeddhaMadhavi ReddyPublished in: Critical reviews in food science and nutrition (2022)
Cancer prevalence is rising rapidly around the globe, contributing immensely to the burden on health systems, hence the search for more effective and selective treatments still remains enticing. Whey, as a natural source, has received extensive focus in recent years because of its intriguing applications to health benefits. Growing consumer appreciation of the nutraceutical effects of whey components makes them an attractive field within cancer research. Whey is a valuable source of superior-quality proteins, lactose, vitamins, and minerals that contribute to proper nutrition as well as help hamper illness and even complement certain disease-related therapy prognosis. As a result, industry leaders and dairy producers are devising new ways to valorize it. Great emphasis on cancer prevention and treatment has been given to whey protein (WP) by the scientific community. WP intake has been proven to induce anti-cancer effects in various in vitro and in vivo studies. Nutritionists and dietitians are now enormously endorsing the role of WP in the therapeutic field, notably for cancer cachexia management. However, human intervention studies with WP are in their infancy and remain to be established with different tumor entities to provide valid proof of its ability to act as a coadjuvant in cancer treatment.
Keyphrases
- papillary thyroid
- squamous cell
- randomized controlled trial
- healthcare
- systematic review
- stem cells
- lymph node metastasis
- endothelial cells
- public health
- squamous cell carcinoma
- small molecule
- mental health
- physical activity
- childhood cancer
- health information
- risk factors
- bone marrow
- mesenchymal stem cells
- smoking cessation
- body mass index
- protein protein
- weight gain
- cell therapy
- social media
- quality improvement
- human health
- induced pluripotent stem cells
- case control